Related Experiment Videos
[Ketanserin and random skin flaps. An experimental study in the rat]
J Achouche1, B Teisseire, O Laccourreye
1Unité de chirurgie plastique, Hôpital Lariboisière, Université Paris VII.
Annales De Chirurgie Plastique Et Esthetique
|April 1, 1994
Summary
Ketanserin, a serotonin antagonist, improved random skin flap survival in rats. Necrosis was significantly reduced in rats receiving ketanserin injections, showing its therapeutic potential.
Area of Science:
- Pharmacology
- Surgical Research
- Wound Healing
Context:
- Random skin flaps are crucial in reconstructive surgery.
- Flap survival is often compromised by ischemia and reperfusion injury.
- Serotonin plays a role in vascular tone and inflammation, impacting flap viability.
Purpose:
- To evaluate the efficacy of ketanserin, a serotonin antagonist, in improving random skin flap survival.
- To determine the statistical significance of ketanserin's effect on reducing skin necrosis.
Summary:
- A prospective randomized study was conducted in a Wistar rat model.
- Rats received pre- and post-operative subcutaneous ketanserin injections.
- The surface area of skin necrosis was significantly lower in the ketanserin-treated group compared to controls.
Impact:
- Ketanserin demonstrates statistically significant value in enhancing random skin flap survival.
- This finding suggests ketanserin as a potential therapeutic agent to improve outcomes in reconstructive surgery.
- Further research may explore clinical applications of ketanserin in patients undergoing flap surgery.